HYEX — Healthy Extracts Income Statement
0.000.00%
- $10.18m
- $11.00m
- $3.11m
- 51
- 20
- 42
- 30
Annual income statement for Healthy Extracts, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.28 | 1.68 | 2.25 | 2.49 | 3.11 |
Cost of Revenue | |||||
Gross Profit | -0.578 | 1.12 | 1.47 | 1.62 | 1.91 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.83 | 3.53 | 3.16 | 4.73 | 3.3 |
Operating Profit | -3.56 | -1.85 | -0.912 | -2.24 | -0.183 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.58 | -1.99 | -0.983 | -2.47 | -0.841 |
Net Income After Taxes | -2.58 | -1.99 | -0.983 | -2.47 | -0.841 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.58 | -1.99 | -0.983 | -2.47 | -0.841 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.58 | -1.99 | -0.983 | -2.47 | -0.841 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.543 | -0.603 | -0.312 | -0.848 | -0.282 |